1 Mins
31 May 2018
Resolution of Ascites, Hepatic Encephalopathy, and Variceal Bleeding in Patients with Hepatitis C Virus and Decompensated Cirrhosis Who Received All-Oral Direct-Acting Antiviral Treatment
Worldwide, 185 million people are infected with the hepatitis C virus (HCV);1 approximately 12% of these individuals have manifestations of decompensated…
1 Mins
31 May 2018
A Comparison of Renal Function Before and After Treatment of Chronic Hepatitis C Infection in Patients Who Achieve Sustained Virological Response with Direct-Acting Antivirals
Approximately 3 million people have chronic hepatitis C virus (HCV) infection in the USA. However, there are limited data with regard to the effect of…
2 Mins
31 May 2018
OPTIMIS: Real-World Data in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolisation: Second Interim Analysis
Transarterial chemoembolisation (TACE) is the most common treatment modality for hepatocellular carcinoma (HCC) worldwide, often used to treat cases…
2 Mins
31 May 2018
Monocyte-Derived Hepatocyte-Like Cells in Combination with Proteomics Identify a Potential Biomarker for Drug-Induced Liver Injury by Diclofenac
Drug-induced liver injury (DILI) is the leading cause of acute liver failure leading to death or requiring transplantation in the European Union (EU) and…
Loading posts...